arrow
P

Philippe Chanson

ap-hp hopital de bicetre
H指数:97
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinguishing hyperparathyroidism from insulin-like growth factor I–driven calcium–phosphate metabolism changes in acromegaly

区分继发性甲状旁腺功能亢进与肢端肥大症中胰岛素样生长因子I驱动的钙磷代谢变化

2026-09-220
OAAI
Long-acting growth hormone: an updated Growth Hormone Research Society consensus statement

长效生长激素:生长激素研究学会共识声明更新

2026-09-010
OAAI
P304 - ECE_3632 - Distinguishing primary hyperparathyroidism from IGF-I–induced changes in calcium and phosphate metabolism in acromegaly using routine biochemical markers

P304 - ECE_3632 - 利用常规生化标志物区分原发性甲状旁腺功能亢进症与肢端肥大症中IGF-I诱导的钙和磷酸盐代谢变化

2026-08-100
OAAI
EP1017 - ECE_2448 - The renin-angiotensin system is activated by short-term, but repressed by long-term growth hormone excess

EP1017 - ECE_2448 - 肾素-血管紧张素系统被短期生长激素过量激活,但被长期生长激素过量抑制

2026-08-100
OAAI
Consensus on acromegaly complications: an update

肢端肥大症并发症的共识:最新进展

2026-04-290
OAAI
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM

法国专家共识声明:原发性甲状旁腺功能亢进的诊断与管理

2025-08-300
PRE
Consensus on acromegaly therapeutic outcomes: an update

生长激素腺瘤治疗效果的共识:最新进展

2025-08-130
PREAI
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society

关于生长激素缺乏症诊断的共识与争议:生长激素研究学会的德尔菲调查

2025-05-070
PRE